40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
87.35%
Revenue growth above 1.5x OBE's 7.18%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
167.60%
Gross profit growth above 1.5x OBE's 60.49%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
626.67%
EBIT growth above 1.5x OBE's 88.12%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
626.67%
Operating income growth above 1.5x OBE's 381.82%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
269.37%
Net income growth above 1.5x OBE's 58.76%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
267.80%
EPS growth above 1.5x OBE's 59.15%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
268.94%
Diluted EPS growth above 1.5x OBE's 58.87%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.77%
Share count expansion well above OBE's 0.55%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.01%
Reduced diluted shares while OBE is at 0.60%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-27.09%
Dividend reduction while OBE stands at 2.40%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.91%
Positive OCF growth while OBE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
77.45%
FCF growth 50-75% of OBE's 150.88%. Martin Whitman would see if structural disadvantages exist in generating free cash.
48.21%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-72.38%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
35.33%
Positive 3Y CAGR while OBE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-20.66%
Negative 10Y OCF/share CAGR while OBE stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-71.73%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-37.84%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
64.92%
Positive 10Y CAGR while OBE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-39.07%
Negative 5Y net income/share CAGR while OBE is 90.32%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
244.85%
Positive short-term CAGR while OBE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-17.51%
Negative equity/share CAGR over 10 years while OBE stands at 44.48%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-74.01%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-68.30%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
305.40%
Dividend/share CAGR of 305.40% while OBE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-63.33%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-26.38%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-13.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-19.51%
Inventory is declining while OBE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.54%
Positive asset growth while OBE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
12.03%
Positive BV/share change while OBE is negative. John Neff sees a clear edge over a competitor losing equity.
-0.22%
We’re deleveraging while OBE stands at 5.50%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
We cut SG&A while OBE invests at 11.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.